TV.QIAGENBIOINFORMATICS.COM
QIAGEN IPA
QIAGEN IPA deep-dive and new features training, America - Nov 3 2021
As requested by many users, your QIAGEN Digital Insights team is excited to introduce...
QIAGEN OmicSoft and Biomedical Knowledge Base
Biomarkers and drug target investigation using manually curated, unified...
There is an almost incomprehensible amount of diverse, non-standardized ‘omics data...
QIAGEN IPA
From Signature to Strategy: Drug Repurposing and Indication Expansion with...
Discover how QIAGEN Ingenuity Pathway Analysis (IPA) and OmicSoft Studio empower...
QIAGEN OmicSoft and Biomedical Knowledge Base
OmicSoft Explorer Hands-on Workshop: Easily search and interpret deeply...
This hands-on workshop will cover a highly requested use case using OmicSoft Explorer...
QIAGEN IPA
Single-cell RNA-seq data interpretation using QIAGEN IPA
In this webinar, the speaker will go over how to: • Identify critical pathways and...
QIAGEN IPA
‘Omics to Insights: Leveraging QIAGEN IPA for Pre-Clinical Toxicology and...
Pre-clinical toxicology studies generate complex datasets that require robust...
QIAGEN IPA
QIAGEN IPA New User Training
Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your...
QIAGEN CLC Genomics
Single Cell RNA-Seq and Spatial Transcriptomics
In this webinar, the speaker will cover how to simplify your single cell RNA-seq...
QIAGEN CLC Genomics
The increasing Accessibility of Cell Therapy, Gene Therapy, and Clinical...
Precision medicine is rapidly transforming healthcare, and one of the most significant...
QIAGEN CLC Genomics
Mapping the Human Body One Cell at a Time
The 37 trillion cells of the human body have a remarkable array of specialized...
QIAGEN IPA
Investigating biomarkers with bulk and single-cell RNA-seq expression data
QIAGEN Ingenuity Pathway Analysis (IPA) is designed to help you analyze and compare...
QCI PI
Deliver Clinical Molecular Insights at Scale with QCI Precision Insights
Cancer care has been transformed by comprehensive molecular profiling and targeted...